Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Auto-FMT for Microbiome Restoration Post H. Pylori Therapy
NCT05329636Phase 2Recruiting
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Sep 2018
- Primary completion
- Jul 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of fecal microbiome transplant in Helicobacter pylori infection, sponsored by Tel Aviv Sourasky Medical Center. Started Sep 2018; status: recruiting.
02
Drugs
fecal microbiome transplant
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05329636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05329636.